Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 EUR | 0.00% | +5.19% | -22.12% |
Apr. 23 | Maps, to group company project from Novara Health Authority | AN |
Mar. 28 | Futures tentatively up, eyes on macros | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.12% | 32.16M | - | ||
-10.65% | 197B | A- | ||
+12.56% | 169B | B- | ||
+1.57% | 166B | B+ | ||
+5.85% | 101B | A- | ||
+5.79% | 76.87B | A- | ||
+16.57% | 71.98B | C- | ||
-6.76% | 71.09B | A | ||
-22.12% | 51.76B | C | ||
+2.76% | 48.08B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MAPS Stock
- Ratings Maps S.p.A.